Anika Therapeutics | ANIK - EPS Earnings Per Share


Anika Therapeutics reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
Agenus USD 1.02 1.32 Mar/2026
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.46 0.4 Sep/2026
Integra LifeSciences USD 0.6 0.04 Sep/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.7 0.2 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.67 0.3 Sep/2026
MacroGenics USD 0.31 0.89 Jun/2026
Merit Medical Systems USD 1.12 0.07 Sep/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 3.55 1.46 Sep/2026
Smith & Nephew USD 0.47 0.12 Jun/2026
Stryker USD 3.52 0.17 Sep/2026
Veracyte USD 0.51 0.03 Sep/2026
Xencor USD 0.5 0.79 Sep/2026
Zimmer Biomet Holdings USD 1.9 0.17 Sep/2026